Navigation Links
Arena Pharmaceuticals Announces Third Quarter 2009 Financial Results and Recent Developments
Date:11/9/2009

t at least 10% of their weight, compared to 16.1% for placebo. The average weight loss for lorcaserin patients dosed twice daily was 17.0 pounds, compared to 8.7 pounds for placebo. The top quartile of lorcaserin patients who completed the trial according to protocol and had their Week 52 weight recorded lost an average of 35.1 pounds. Lorcaserin was very well tolerated and no excess depression or suicidal ideation was observed with lorcaserin treatment. The incidence of new FDA-defined valvulopathy from the integrated echocardiographic data set from BLOSSOM and BLOOM did not differ from placebo.
  • Announced a late-breaking oral presentation from the pivotal BLOSSOM trial and additional positive data from the pivotal BLOOM trial at the 27th Annual Scientific Meeting of The Obesity Society. The new BLOSSOM data demonstrate improvements in patients' body composition, cardiovascular risk factors and quality of life. The new BLOOM data demonstrate that lorcaserin significantly improved markers of cardiovascular risk and glycemic parameters and was not associated with depression or suicidal ideation. Lorcaserin patients who completed the BLOOM trial according to protocol lost 31% of their excess body weight, compared to 12% for the placebo group.
  • Completed dosing in all lorcaserin clinical trials Arena expects to be included in the NDA it plans to submit to the FDA by the end of 2009.
  • Completed a public offering of 12.5 million shares of common stock, resulting in net proceeds to Arena of $49.7 million.
  • Received net proceeds of $95.6 million from a $100.0 million loan provided by Deerfield Management. The outstanding principal accrues interest until maturity in June 2013 at a rate of 7.75% per annum. In connection with the loan, Arena issued Deerfield warrants for 28 million shares of its common stock at an exercise price of $5.42 per share. On or before June 17, 2011, Deerfield may make a one-time election to provide Arena with up to an add
    '/>"/>

  • SOURCE Arena Pharmaceuticals, Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine technology :

    1. Arena Pharmaceuticals to Present at Four Upcoming Investor Conferences
    2. Arena Pharmaceuticals Announces Positive Phase 2 Clinical Trial Results of APD125 for the Treatment of Insomnia
    3. Arena Pharmaceuticals Announces APD668 Initial Clinical Study Results Suggest Glucose-Dependent Insulinotropic Receptors May Improve Glucose Control in Patients With Type 2 Diabetes
    4. Arena Pharmaceuticals Announces Positive Phase 1a Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis and Initiates Phase 1b Clinical Trial
    5. Arena Pharmaceuticals Initiates Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
    6. Arena Pharmaceuticals, Inc. Announces Initiation of Phase 1 Clinical Trial of Drug Candidate Under Partnership with Taisho Pharmaceutical Co., Ltd.
    7. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
    8. Arena Pharmaceuticals Announces Positive Phase 1b Clinical Trial Results of APD791 for the Treatment of Arterial Thrombosis
    9. Critical Pharmaceuticals Enter Sustained Release hGH Arena
    10. Arena Pharmaceuticals Announces Preliminary Results of Phase 2b Clinical Trial of APD125 for the Treatment of Insomnia
    11. Arena Pharmaceuticals Announces Initiation of Phase 1 Clinical Trial of Type 2 Diabetes Drug Candidate in Partnership with Ortho-McNeil-Janssen Pharmaceuticals
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/23/2014)... Research and Markets has announced ... and Surgical) Markets Worldwide 2014" report to their ... The purpose of this report is to analyze ... and Surgical) Gloves. The report discusses key players and ... Topics covered include product definitions, strategies, competitive analysis, ...
    (Date:7/23/2014)... , July 23, 2014  The management team ... ) will hold a conference call on July ... second quarter ended June 30, 2014.  The call ... 2014Time: , 8:30 am EDTDial-in numbers: , Toll ... (412) 317-0790Webcast (live & archive): , www.columbialabs.com ...
    (Date:7/23/2014)... July 23, 2014  Silk Road Medical, Inc., ... treatment of intra- and extra-cranial cerebrovascular disease, announced ... to the position of Chief Technology Officer.  ... company,s Research and Development efforts across its family ... Prior to joining Silk Road Medical, Michael ...
    Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
    ... , , SANTA MONICA, ... the winners of the ,Give Thanks for Loved Ones, Brain Health ... the symptoms of dementia and Alzheimer,s disease. All five winners will ... to help seniors preserve their brain health and the most widely ...
    ... , , KNOXVILLE, Tenn., Dec. 15 ... attention with their revolutionary new technology for a simple blood ... the success of its pre-clinical trials for the ColoMarker(TM) assay, ... all aspects of its use. Via an inexpensive blood ...
    Cached Medicine Technology:5 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 2
    (Date:7/23/2014)... 23, 2014 Four hospitals affiliated with ... in the latest ranking of the country’s best hospitals ... Released online today and slated for publication in August, ... General Hospital (AGH), Forbes Hospital, Saint Vincent Hospital and ... multiple clinical specialties. , “There is no ...
    (Date:7/23/2014)... WEDNESDAY, July 23, 2014 (HealthDay News) --,Jealousy may not ... showing dogs can get downright possessive when it comes ... owners showed affection toward what was actually a stuffed ... snapping or pushing the stuffed dog aside, report researchers ... This jealous streak only surfaced when owners were attending ...
    (Date:7/23/2014)... In a massive effort to catalog the ... at Dana-Farber Cancer Institute, have identified four subtypes ... molecular abnormalities. They say the new classification promises ... for the third-leading cancer killer worldwide. , In ... The Cancer Genome Atlas Research Network said they ...
    (Date:7/23/2014)... Texas Physical Therapy Specialists (TexPTS) is ... Westlake, Westgate, Liberty Hill, Parmer, Balcones, and Georgetown clinics ... Orthopaedic Certified Specialist (OCS) or Sports ... DPT, OCS, Tony Lauretta, PT, DPT, OCS, Jason Brown, ... Leech, PT, DPT, OCS, and Mary Grimberg, PT, DPT, ...
    (Date:7/23/2014)... 2014 A therapy combining salmon fibrin injections into ... into the brain restored voluntary motor function impaired by ... Center have found. , In a study on rodents, ... turning back the developmental clock in a molecular pathway ... and providing a scaffold so that neuronal axons at ...
    Breaking Medicine News(10 mins):Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Dogs Can Get Jealous, Too 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 2Health News:Texas Physical Therapy Specialists Congratulates New Board Certified Specialists 3Health News:Gene inhibitor, salmon fibrin restore function lost in spinal cord injury 2
    ... it time for all community-based doctors to turn to e-prescribing ... According to Rainu Kaushal and colleagues from the Weill Cornell ... prescribing errors up to seven-fold. Their study of ... in the Journal of General Internal Medicine , published ...
    ... ... renowned publication, The Leading Physicians of the World. Dr. Sood will be representing the ... dermatologists from all over the globe. , ... New York, NY (PRWEB) February 22, 2010 -- As owner of Harper Dermatology ...
    ... ... ... ... ...
    ... ... ... ... ...
    ... proven to enhance bone density and reduce fracture incidence ... increase risk of atypical fractures of the femur when ... research presented today at the 2010 Annual Meeting of ... Bisphosphonates are designed to slow or stop the ...
    ... , ... best selling author David S. Linthicum kicks off the Webinar series with Best Practices in ... ... of the Leveraging Cloud Computing Within the Modern Data Center webinar series. These media ...
    Cached Medicine News:Health News:Physicians click their way to better prescriptions 2Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 2Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 3Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 4Health News:Neuro Drinks Provide Sparkling Refreshment on a Star-Studded Evening at the 18th Annual Academy Awards(R) Viewing Party Hosted by the Elton John AIDS Foundation 5Health News:Kimberly-Clark Introduces Kleenex Hand Towels 2Health News:Kimberly-Clark Introduces Kleenex Hand Towels 3Health News:Kimberly-Clark Introduces Kleenex Hand Towels 4Health News:Kimberly-Clark Introduces Kleenex Hand Towels 5Health News:Kimberly-Clark Introduces Kleenex Hand Towels 6Health News:Quantity vs. quality: Long-term use of bone-building osteoporosis drugs 2Health News:Quantity vs. quality: Long-term use of bone-building osteoporosis drugs 3Health News:Bick Group Launches Leveraging Cloud Computing Within the Modern Data Center Webinar Series 2
    This fixed-volume digital micropipet is used to accurately measure and transfer 5 microliters of solution....
    ... A fixed pipette is ideal ... single volume. Fixed volume FInnpipettes ... advantages as other Finnpipette Digital ... Super blow-out (1-40ul), Soft-touch tip ...
    10L...
    ... ergonomics, and value!, Comfortable feel ... non-slip, contoured handle , Finer control ... spring action , Completely autoclavable for ... need for recalibration , Easy-to-read precision ...
    Medicine Products: